Proteome profiling allows evaluating resistance mechanisms of tumor cells against the anticancer Ruthenium compound KP1339
- Dominique Kreutz (Contributor)
- Michael Größl (Contributor)
- Ammar Tahir (Contributor)
- Petra Heffeter (Contributor)
- Walter Berger (Contributor)
- Keppler, B. (Contributor)
- Gerner, C. (Contributor)
Activity: Talks and presentations › Poster presentation › Science to Science